China Universal Asset Management Co., Ltd.
Position in RAPP — Rapport Therapeutics, Inc.
CIK 1906594
SHANGHAI, F4
Position in RAPP
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$450,536
+$73,242 QoQ
Shares Held
10,812
-10.3% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#95
of 159 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RAPP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026China Universal Asset Management Co., Ltd. holds $181,209,200 across 241 Biotechnology names. RAPP ranks #75 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
48,265 | $23,974,673 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,498 | $12,157,782 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
25,269 | $7,606,727 | |
| 4 | RPRX |
Royalty Pharma plc
|
120,547 | $6,759,070 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
33,835 | $6,336,618 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
76,302 | $6,049,985 | |
| 7 | MRNA |
Moderna, Inc.
|
63,149 | $4,422,324 | |
| 8 | ARGX |
Argenx SE
|
4,642 | $4,306,708 |
All Filings in RAPP
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $450,536 | 10,812 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $377,294 | 12,058 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $326,640 | 10,766 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $219,720 | 7,398 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $83,342 | 7,330 | Shares | Sole | 2025-08-28 | |
| 2025-03-31 | $73,590 | 7,337 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $137,591 | 7,756 | Shares | Sole | 2025-01-24 | |
| No filing history on record for this holder in this stock. | ||||||